US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 20, 2012 (14 years ago)

Children's Cetirizine HCl Chewable Tablets 5 mg

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2)

What was recalled

Children's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ NDC 0781-5283-64 --- ALSO sold under Major brand All Day Allergy Children's Cetirizine HCl 5 mg, 5 count blister pack, Major Pharmaceuticals, Livonia, MI NDC 0904-5878-33

Recalling firm
Sandoz Incorporated
NDC code
0781-5283-64
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-008-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cetirizine recalls

See all
Class I · High risk Ongoing

Cetirizine Hydrochloride Tablets USP 5 mg

Reason Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

JB Chemicals and Pharmaceuticals Ltd NDC 16571-401-10 D-0732-2026
Class II · Moderate risk Ongoing

Cetirizine Hydrochloride Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 72657-129-35 D-0348-2025